US FDA grants tentative approval for Sun's generic Aricept
30 Nov 2010
1
Mumbai: Sun Pharmaceutical today said that ther US FDA has granted a tentative approval for an abbreviated new drug application to market its generic version of Aricept, donepezil hydrochloride tablets, used in the treatment of dementia.
These generic donepezil hydrochloride tablets, equivalent to Eisai's aricept tablets, include two strengths: 5 mg and 10 mg, the annual sales of which in the US is approximately $2.5 billion.
Donepezil hydrochloride tablets are indicated in the treatment of dementia of the Alzheimer's type.
Efficiency has been demonstrated in patients with mild, moderate and severe Alzheimer's disease, Sun said in a statement.
Aricept is a registered trademark of Japan's Eisai co. Ltd.
.jpg "RBI keeps repo rate unchanged as focus remains on inflation")
.jpg "Indian Oil, Panasonic team up for lithium-ion cell production in India")
